Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19”
Laura Ambra Nicolini(Ospedale Policlinico San Martino), Matteo Bassetti(Ospedale Policlinico San Martino), Małgorzata Mikulska(Ospedale Policlinico San Martino), Alessio Signori(University of Genoa), Mauro Giacomini(University of Genoa), Federica Portunato(Ospedale Policlinico San Martino), Antonio Vena(Ospedale Policlinico San Martino), Antonio Di Biagio
Cited by 8
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#
|Intensive Care Medicine|2020|1.1k